• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用从患者血小板和白细胞中分离的 RNA 研究 von Willebrand 因子剪接突变的影响。

The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients' platelets and leukocytes.

机构信息

Unitat de Diagnòstic i Teràpia Molecular, Banc de Sang i Teixits, Barcelona, Spain.

出版信息

J Thromb Haemost. 2011 Apr;9(4):679-88. doi: 10.1111/j.1538-7836.2011.04204.x.

DOI:10.1111/j.1538-7836.2011.04204.x
PMID:21251206
Abstract

BACKGROUND

In von Willebrand factor (VWF) the effect of mutations potentially affecting mRNA processing or splicing is less predictable than that of other mutations (e.g. nonsense or missense substitutions). Bioinformatic tools can provide a valuable means to determine the consequences of potential splice site mutations (PSSM), but functional studies are mandatory to elucidate the true effect of the variation detected.

OBJECTIVES, PATIENTS AND METHODS: After identification of PSSM in VWD patients, we began a systematic study of their in vivo effect in RNA extracted from the patients' platelets and leukocytes.

RESULTS AND CONCLUSIONS

Thirteen pairs of primers were designed for full amplification of VWF mRNA by RT-PCR that, after sequencing of aberrant products, enabled elucidation of the PSSM consequences for mRNA processing. This procedure was used to study seven different PSSM identified in four patients demonstrating diverse molecular mechanisms such as exon skipping (c.533-2A>G and c.8155+3G>C) and the activation of a cryptic splice site (c.7730-1G>C). No visible effect was evident for c.1533+15G>A and c.5170+10C>T and the consequence of c.[546G>A;7082-2A>G] was hidden by nonsense-mediated mRNA decay (NMD). Results were compared with in silico predictions of four splice-site analysis tools. We demonstrate selective degradation of VWF mRNA bearing PSSM by NMD for several mutations, which suggests that NMD represents a general mechanism for truncating mutations in VWF. Furthermore, because NMD efficiency varies between cell types, use of RNA from both platelets and leukocytes for in vivo study of VWF PSSM offers complementary results, particularly in cases in which NMD occurs in the allele carrying the mutation.

摘要

背景

在血管性血友病因子 (VWF) 中,潜在影响 mRNA 处理或剪接的突变的影响比其他突变(例如无义或错义取代)更难预测。生物信息学工具可以提供一种有价值的方法来确定潜在剪接位点突变 (PSSM) 的后果,但功能研究是阐明检测到的变异的真实影响所必需的。

目的、患者和方法:在鉴定 VWD 患者的 PSSM 后,我们开始对从患者血小板和白细胞中提取的 RNA 中 PSSM 的体内效应进行系统研究。

结果和结论

设计了 13 对引物,通过 RT-PCR 对 VWF mRNA 进行完全扩增,在对异常产物进行测序后,阐明了 PSSM 对 mRNA 处理的影响。该程序用于研究在四名患者中鉴定的七种不同的 PSSM,这些患者表现出不同的分子机制,如外显子跳跃(c.533-2A>G 和 c.8155+3G>C)和激活隐匿剪接位点(c.7730-1G>C)。c.1533+15G>A 和 c.5170+10C>T 没有明显的影响,c.[546G>A;7082-2A>G] 的后果被无义介导的 mRNA 衰减 (NMD) 隐藏。结果与四种剪接位点分析工具的计算机预测进行了比较。我们证明了 NMD 对几种 PSSM 导致的 VWF mRNA 的选择性降解,这表明 NMD 是 VWF 截断突变的一种普遍机制。此外,由于 NMD 效率在细胞类型之间存在差异,因此使用血小板和白细胞中的 RNA 进行 VWF PSSM 的体内研究可提供互补结果,特别是在 NMD 发生在携带突变的等位基因的情况下。

相似文献

1
The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients' platelets and leukocytes.利用从患者血小板和白细胞中分离的 RNA 研究 von Willebrand 因子剪接突变的影响。
J Thromb Haemost. 2011 Apr;9(4):679-88. doi: 10.1111/j.1538-7836.2011.04204.x.
2
Unraveling the effect of silent, intronic and missense mutations on splicing: contribution of next generation sequencing in the study of mRNA.解析沉默突变、内含子突变和错义突变对剪接的影响:下一代测序在 mRNA 研究中的贡献。
Haematologica. 2019 Mar;104(3):587-598. doi: 10.3324/haematol.2018.203166. Epub 2018 Oct 25.
3
Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factor.揭示血管性血友病因子九个假定剪接位点变异的分子基础。
Hum Mutat. 2022 Feb;43(2):215-227. doi: 10.1002/humu.24312. Epub 2021 Dec 17.
4
A synonymous (c.3390C>T) or a splice-site (c.3380-2A>G) mutation causes exon 26 skipping in four patients with von Willebrand disease (2A/IIE).一个同义突变(c.3390C>T)或剪接位点突变(c.3380-2A>G)导致了四名血管性血友病患者(2A/IIE)外显子 26 的跳跃。
J Thromb Haemost. 2013 Jul;11(7):1251-9. doi: 10.1111/jth.12280.
5
Alterations of mRNA processing and stability as a pathogenic mechanism in von Willebrand factor quantitative deficiencies.mRNA 加工和稳定性改变作为 von Willebrand 因子定量缺陷的致病机制。
J Thromb Haemost. 2010 Dec;8(12):2736-42. doi: 10.1111/j.1538-7836.2010.04060.x.
6
Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.血管性血友病因子在血管性血友病中异常剪接的特征:一种未被充分认识的机制
Blood. 2016 Jul 28;128(4):584-93. doi: 10.1182/blood-2015-10-678052. Epub 2016 Jun 17.
7
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.联合部分外显子跳跃和隐蔽剪接位点激活作为1型遗传性血管性血友病隐性型的一种新分子机制。
Thromb Haemost. 2006 Dec;96(6):711-6.
8
Nonsense mediated decay of VWF mRNA subsequent to c.7674-7675insC mutation in type3 VWD patients.3 型血管性血友病患者 c.7674-7675insC 突变后导致血管性血友病因子 mRNA 无意义介导衰变。
Blood Cells Mol Dis. 2012 Jun 15;49(1):48-52. doi: 10.1016/j.bcmd.2012.03.007. Epub 2012 Apr 12.
9
Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets.表达含有与IIB型血管性血友病相关错义突变的全长血管性血友病因子,显示出与血小板的结合增强。
Blood. 1992 Apr 15;79(8):2048-55.
10
Molecular characterization of ten F8 splicing mutations in RNA isolated from patient's leucocytes: assessment of in silico prediction tools accuracy.从患者白细胞中分离的RNA中十个F8剪接突变的分子特征:计算机预测工具准确性评估
Haemophilia. 2015 Mar;21(2):249-257. doi: 10.1111/hae.12562. Epub 2015 Feb 5.

引用本文的文献

1
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.3WINTERS-IPS 研究中登记的 3 型血管性血友病欧洲和伊朗患者的基因型。
Blood Adv. 2021 Aug 10;5(15):2987-3001. doi: 10.1182/bloodadvances.2020003397.
2
Cryptic non-canonical splice site activation is part of the mechanism that abolishes multimer organization in the c.2269_2270del von Willebrand factor.隐匿性非规范剪接位点激活是消除 c.2269_2270del 血管性血友病因子多聚体结构的机制的一部分。
Haematologica. 2020 Apr;105(4):1120-1128. doi: 10.3324/haematol.2019.222679. Epub 2019 Jul 18.
3
Unraveling the effect of silent, intronic and missense mutations on splicing: contribution of next generation sequencing in the study of mRNA.
解析沉默突变、内含子突变和错义突变对剪接的影响:下一代测序在 mRNA 研究中的贡献。
Haematologica. 2019 Mar;104(3):587-598. doi: 10.3324/haematol.2018.203166. Epub 2018 Oct 25.
4
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients.西班牙血管性血友病患者的分子和临床特征(PCM-EVW-ES):480 例患者下一代测序的全面基因分析。
Haematologica. 2017 Dec;102(12):2005-2014. doi: 10.3324/haematol.2017.168765. Epub 2017 Sep 29.
5
Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis.利用因子XI水平作为血栓形成的中间表型,通过下一代测序剖析KNG1和F11基因座的遗传结构。
PLoS One. 2017 Apr 26;12(4):e0176301. doi: 10.1371/journal.pone.0176301. eCollection 2017.
6
The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease.纤溶酶原缺乏症的遗传结构解析及其与血栓性疾病的关系。
Sci Rep. 2016 Dec 15;6:39255. doi: 10.1038/srep39255.
7
Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.血管性血友病因子在血管性血友病中异常剪接的特征:一种未被充分认识的机制
Blood. 2016 Jul 28;128(4):584-93. doi: 10.1182/blood-2015-10-678052. Epub 2016 Jun 17.
8
Nonsense-mediated mRNA decay among coagulation factor genes.凝血因子基因中的无义介导的mRNA降解
Iran J Basic Med Sci. 2016 Apr;19(4):344-9.